Carotid Intimal-Media Thickness as a Surrogate for Cardiovascular Disease Events in Trials of HMG-CoA Reductase Inhibitors

Current Controlled Trials in Cardiovascular Medicine
doi 10.1186/1468-6708-6-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Comparative Study of Carotid Intima Media Thickness as a Surrogate Marker for Cardiovascular Events in Rural Dakshina Kannada Population

Journal of Evolution of Medical and Dental Sciences
2015English

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

2009English

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis

Cochrane Database of Systematic Reviews
2014English

Carotid Intima‐Media Thickness and Prediction of Cardiovascular Disease

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2017English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

ISRN Dentistry
2011English

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

JAMA - Journal of the American Medical Association
Medicine
2000English

Role of HMG-CoA Reductase Inhibitors With Curative Radiotherapy in Men With Prostate Cancer

Research and Reports in Urology
Urology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy